| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/18/2008 | WO2008111996A2 Muc1-ikb kinase complexes and their activities |
| 09/18/2008 | WO2008111908A1 Five- and six-membered conformationally locked 2',4'- carbocyclic ribo-thymidines for the treatment of infections and cancer |
| 09/18/2008 | WO2008111597A1 Remedy for chemotherapy-resistant cancer containing hla class i-recognizing antibody as the active ingredient and use of the same |
| 09/18/2008 | WO2008111526A1 Method for production of sugar oxazoline derivative |
| 09/18/2008 | WO2008111520A1 Gene related to life extension and use thereof |
| 09/18/2008 | WO2008111450A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 09/18/2008 | WO2008111441A1 Pharmaceutical composition |
| 09/18/2008 | WO2008111430A1 METHOD FOR PRODUCING γδT CELL POPULATION |
| 09/18/2008 | WO2008111244A1 External preparation for skin, and food |
| 09/18/2008 | WO2008111082A1 Process for the synthesis of ib-meca |
| 09/18/2008 | WO2008111010A1 Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors |
| 09/18/2008 | WO2008111009A1 Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors |
| 09/18/2008 | WO2008110846A2 Compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases |
| 09/18/2008 | WO2008110794A1 Piperidinones useful in the treatment of inflammation |
| 09/18/2008 | WO2008110793A1 Piperidinones useful in the treatment of inflammation |
| 09/18/2008 | WO2008110691A1 Novel tricyclic derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/18/2008 | WO2008110624A2 Sirna-mediated silencing of genes for treating chemotherapeutic drug-resistant epithelial tumors |
| 09/18/2008 | WO2008110583A1 Amide compounds and their use as antitumor agents |
| 09/18/2008 | WO2008110491A2 Chemotherapy of neoplastic diseases using combinations of rapamycin and compounds modulating mtor pathway alone or in combination with heat |
| 09/18/2008 | WO2008110379A2 Monoclonal antibodies for treatment of cancer |
| 09/18/2008 | WO2008110373A1 Method of providing human tumor-specific antibodies |
| 09/18/2008 | WO2008110372A1 Monoclonal human tumor-specific antibody |
| 09/18/2008 | WO2008110065A1 Compositions and methods for treating cancer |
| 09/18/2008 | WO2008110006A1 Biomarkers of prostate cancer and uses thereof |
| 09/18/2008 | WO2008110004A1 Reoviruses having modified sequences |
| 09/18/2008 | WO2008109997A1 Procaspase 8-mediated disease targeting |
| 09/18/2008 | WO2008109996A1 Assessing chemotherapy resistance of colorectal tumors by determining sparc hypermethylation |
| 09/18/2008 | WO2008109994A1 Inhibitors of histone deacetylase |
| 09/18/2008 | WO2008109992A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/18/2008 | WO2008109991A1 Inhibitors of carnitine palmitoyltransferase and treating cancer |
| 09/18/2008 | WO2008109976A1 Kunitz-type recombinant inhibitor |
| 09/18/2008 | WO2008109972A1 Homeopathic medicament useful for immunomodulation |
| 09/18/2008 | WO2008109953A1 Method for treating cancer via the mucosal administration of interleukin |
| 09/18/2008 | WO2008109943A1 Phenyl amino pyrimidine compounds and uses thereof |
| 09/18/2008 | WO2008091620A3 Combination therapy comprising romidepsin and i.a. bortezomib |
| 09/18/2008 | WO2008090286A3 Derivatives of imidazo, pyrimido and diazepine pyrimidine-dione, and use thereof as a drug |
| 09/18/2008 | WO2008090177A3 Diagnosis of prostate cancer |
| 09/18/2008 | WO2008084241A3 Use of aminolevulinic acid and derivatives thereof |
| 09/18/2008 | WO2008082637A9 Composition and methods for modulating a kinase cascade |
| 09/18/2008 | WO2008076379A3 Human antibodies to human delta like ligand 4 |
| 09/18/2008 | WO2008020039A3 2,5-dihydroxybenzene compounds for treating cancers and hematological dyscrasias |
| 09/18/2008 | WO2007104933A8 Chemical compounds |
| 09/18/2008 | US20080227961 Chelation compounds, radionuclides |
| 09/18/2008 | US20080227957 Reducing Immunogenicities of Immunoglobulins by Framework-Patching |
| 09/18/2008 | US20080227954 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |
| 09/18/2008 | US20080227870 Contacting cells with a carcinogen-extracting solvent of a perfluorocarbon liquid such as perfluorodecalin, perfluorooctyl bromide or a Fluorinet" liquid; biocompatability; prophylactically reducing the risk of cancerous cell transformation; lipophilic to dissolve from cell membrane |
| 09/18/2008 | US20080227869 Substituted nitrobenzene derivatives as pharmaceutical and other uses thereof |
| 09/18/2008 | US20080227853 Administering catechin, epicatechin, and derivatives thereof; apoptosis; cancer; microencapsulation |
| 09/18/2008 | US20080227852 such as: 3-Deoxyschweinfurthin B; anticancer assay; e.g. breast cancer or a cancer of the CNS or renal system diagnosis |
| 09/18/2008 | US20080227851 psoriasis, eczema, multiple sclerosis, and arthritis; cross-metathesis reaction being promoted by a cross-metathesis catalyst |
| 09/18/2008 | US20080227845 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 09/18/2008 | US20080227841 Intravesical apaziquone administration following transurethral resection |
| 09/18/2008 | US20080227833 Selective inhibitors of MMP-9 and/or MMP12; antiinflammatory agents for multiple sclerosis and fibrosis; 3R-[2,2-Dimethyl-1 S-(5-phenyl-[1,2,4]oxadiazol-3-yl)-propylcarbamoyl]-2S-hydroxy-5-methyl-hexanohydroxamic acid; bone resorption, metastases, rheumatoid arthritis, Crohn's disease |
| 09/18/2008 | US20080227828 Aryl Ureas With Angiogenisis Inhibiting Activity |
| 09/18/2008 | US20080227827 Compounds that abrogate dna damage induced cell cycle g2 checkpoint and/or augment anti-cancer activity of dna-damaging treatments |
| 09/18/2008 | US20080227826 Such as (S)-2-(Dimethylamino)ethyl-1-(4-(2-aminophenylcarbamoyl)-phenyl)pyrrolidin-3-ylcarbamate for treating cell proliferative disorders |
| 09/18/2008 | US20080227821 N-substituted tricyclic 3-aminopyrazoles as anti-mitotic tubulin polymerization inhibitors |
| 09/18/2008 | US20080227812 Spiro Substituted Compounds As Angiogenesis Inhibitors |
| 09/18/2008 | US20080227811 Benzyl 1-((4-(1H-indol-5-ylamino)-6-methoxyquinolin-7-yloxy)methyl)cyclopropylcarbamate; cancers associated with protein tyrosine kinases |
| 09/18/2008 | US20080227800 Pyrimidylaminobenzamide Derivatives for Hypereosinophilic Syndrome |
| 09/18/2008 | US20080227799 treating or reducing the severity of hyperproliferative diseases by inhibiting metastasis |
| 09/18/2008 | US20080227798 inhibiting dipeptidyl peptidases; diabetes mellitus |
| 09/18/2008 | US20080227789 5-(quinoxalin-2-yl)-N2-(3,4,5-trimethoxyphenyl)thiazole-2,4-diamine; useful in inhibiting the activity of the receptor protein tyrosine kinase Axl; rheumatoid arthritis, vascular disease, vascular injury, psoriasis, visual impairment due to macular degeneration, diabetic retinopathy, retinopathy |
| 09/18/2008 | US20080227779 6-chloro-N-(pyrimidin-5-yl)-3-(3-(trifluoromethyl)phenylamino)benzo[d]isoxazole-7-carboxamide; autoimmune disease, allergies, mastcytosis, mast cell related tumors and various fibrotic diseases |
| 09/18/2008 | US20080227762 Lupeol anti-tumor agent and uses thereof |
| 09/18/2008 | US20080227754 Phosphoramidate linkages; retroviral or hepadnaviral therapy; tissue targeted therapy; HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability |
| 09/18/2008 | US20080227752 Methods to Inhibit Histone Acetyltransferase Using Glycosaminoglycans |
| 09/18/2008 | US20080227741 Zap-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (cll/sll) |
| 09/18/2008 | US20080227740 Compositions and Methods for Elimination of Unwanted Cells |
| 09/18/2008 | US20080227739 Isolated polypeptide comprising amino acid sequence encoded by polynucleotide; physiologically acceptable carriers and immunostimulants |
| 09/18/2008 | US20080227735 Nucleic acid is contactd with cells not expressing receptor protein-tyrosine kinase or expressing it in a nonactivated form (CN cells), contacting first subset S1 of nucleic acids with Ci cells, contacting second subset S2 with CTe cells, amplifying nucleic acids; identifying ligands or aptamers |
| 09/18/2008 | US20080227731 Biphenyl inhibitors of carbonyl reductase |
| 09/18/2008 | US20080227727 Administering topoisomerase inhibitor (such as camptothecin, irinotecan, topotecan, doxorubicin, teniposide, etoposide ) and E3 ubiquitin ligase inhibitor 2-(4-vinylpyridynyl)1,3-diacyl/thiocarbonyl indene derivative for modulating cell growth |
| 09/18/2008 | US20080227724 3-(alkanoyl or alkenoyl)amino-caprolactams; autoimmune diseases, asthma, osteoporosis, transplant rejection, psoriasis, Alzheimer's Disease, Multiple sclerosis, ALS; antitumor, antiarthritic, antifibrotic, and antiscarring agents |
| 09/18/2008 | US20080227720 Tumor cytotoxicity induced by modulators of the CXCR4 receptor |
| 09/18/2008 | US20080227714 Human Tumor Necrosis Factor TR18 and Methods Based Thereon |
| 09/18/2008 | US20080227710 useful in the treatment of hepatocellular carcinomas (HCCs) which do not express the asialoglycoprotein receptor (ASGP-R) and avoids the need of a tumor biopsy |
| 09/18/2008 | US20080227705 Apoptosis-inducing agent and method for inducing apoptosis |
| 09/18/2008 | US20080227701 Antiangiogenic polypeptides and methods for inhibiting angiogenesis |
| 09/18/2008 | US20080227695 reduced expression and/or function of Dlg (discs large) is an important factor for tumor formation; measuring the expression and/or function of Dlg |
| 09/18/2008 | US20080227683 Compounds Having Antitumor Activity |
| 09/18/2008 | US20080227204 Nutrient broth comprising fibronectin and CD-3 specific antibody for use as inductive source for propagation of natural killer cells |
| 09/18/2008 | US20080227127 Human NK3-Related Prostate Specific Gene-1 |
| 09/18/2008 | US20080227106 Compositions and methods for the diagnosis and treatment of tumor |
| 09/18/2008 | US20080227082 Method of identifying a mhc class i restricted t cell response |
| 09/18/2008 | US20080226747 Cell proliferation; anticancer agents; bioavailability |
| 09/18/2008 | US20080226743 Glass filters; anticancer agents |
| 09/18/2008 | US20080226738 Sustained-Released Pellet Formulation of Alpha1-Receptor Antagonist and Process For the Preparation Thereof |
| 09/18/2008 | US20080226732 Nanoparticulate compositions of angiogenesis inhibitors |
| 09/18/2008 | US20080226717 Sublingual Coated Tablet |
| 09/18/2008 | US20080226674 Anticancer drugs encapsulated in and mixed with envelop protein virus vector; intensify immunology response in animals |
| 09/18/2008 | US20080226672 Adjuvant Systems and Vaccines |
| 09/18/2008 | US20080226665 EphA2 T-cell epitopes and uses therefor |
| 09/18/2008 | US20080226664 Colon cancer antigen panel |
| 09/18/2008 | US20080226662 Nucleotide sequences coding mammalian immune system modulator (B7-DC) for use in treatment and prevention of viral infcetion a nd cell proliferative disorders; immunotherapy |
| 09/18/2008 | US20080226657 Monomethylvaline compounds capable of conjugation to ligands |
| 09/18/2008 | US20080226654 Uses of mammalian cytokine; related reagents |
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/18/2008 | US20080226644 Nucleotide sequences coding breast cancer protein (BCMP 101) for use in developing vaccines and immunoglobulin which target and destroy tumor tissues; antitumor agents |
| 09/18/2008 | US20080226643 Compositions and methods for the therapy and diagnosis of breast cancer |